))
James Mackay from Aristea Therapeutics
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on April 04, 2023 20:36 (
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 353376183 series 2971598
Contenu fourni par Daniel Schroeder. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Daniel Schroeder ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
In this episode of the Biotech and Breweries Podcast, James Mackey, CEO of Aristea Therapeutics, a clinical-stage drug development company focused on immunology-focused therapeutics to treat autoimmune and inflammatory diseases. James shares the origin story of Aristea and his long professional history in life sciences. He also shares how fundraising allowed Aristea to extend its development, how Aristea is contributing to the life sciences industry in San Diego, and how the company is finding ways to positively impact the community.
Quote:
“What makes San Diego so special to me is the collaborative nature of everyone here. People are delighted you are here and they want you to succeed. They will do what they can to help you succeed even if you are a competitor because they see success as success for San Diego.” - James Mackey [22:22]
Topics discussed:
- James’ professional journey
- The origins of Aristea and RIST4721
- Fundraising and the life sciences financial market
- Life Science Cares San Diego and SD2
Resources:
Connect with James Mackey:
SUBSCRIBE: Subscribe to the podcast to make sure you never miss an episode.
18 episodes
Partager
